Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PITT COUNTY MEMORIAL HOSPITAL, INC

NPI: 1043218944 · GREENVILLE, NC 27834 · General Acute Care Hospital · NPI assigned 07/13/2005

$60.24M
Total Medicaid Paid
943,128
Total Claims
845,279
Beneficiaries
239
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialZUKOWSKI, ANDREW (CFO)
NPI Enumeration Date07/13/2005

Related Entities

Other providers sharing the same authorized official: ZUKOWSKI, ANDREW

ProviderCityStateTotal Paid
PITT COUNTY MEMORIAL HOSPITAL INC GREENVILLE NC $15.64M
PITT COUNTY MEMORIAL HOSPITAL INC WASHINGTON NC $2.97M
VIDANT MEDICAL GROUP AFFILIATES LLC GREENVILLE NC $21K
PITT COUNTY MEMORIAL HOSPITAL INC GREENVILLE NC $30.02

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 133,313 $7.41M
2019 112,988 $6.64M
2020 100,127 $6.22M
2021 216,027 $13.65M
2022 154,002 $11.19M
2023 119,577 $8.38M
2024 107,094 $6.75M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 103,802 100,288 $15.06M
99284 Emergency department visit for the evaluation and management, high severity 48,556 46,324 $13.80M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 66,206 57,381 $5.62M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 25,488 24,484 $4.71M
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 71,427 63,177 $1.95M
0225U 4,256 3,802 $1.54M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 49,362 43,147 $1.41M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 3,691 3,474 $1.33M
A0431 Ambulance service, conventional air services, transport, one way (rotary wing) 570 340 $1.10M
99282 Emergency department visit for the evaluation and management, low to moderate severity 13,105 12,775 $1.09M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 40,881 36,092 $993K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 110,594 95,176 $956K
95810 Polysomnography; sleep staging with 4 or more additional parameters 962 928 $901K
71046 Radiologic examination, chest; 2 views 8,485 8,175 $729K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 12,392 11,608 $661K
G0378 Hospital observation service, per hour 3,105 2,639 $584K
80053 Comprehensive metabolic panel 56,596 45,177 $554K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 11,772 11,265 $380K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 7,943 6,988 $370K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 11,088 10,604 $362K
J0585 Injection, onabotulinumtoxina, 1 unit 348 325 $301K
A0436 Rotary wing air mileage, per statute mile 568 338 $261K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 2,788 1,651 $256K
P9016 Red blood cells, leukocytes reduced, each unit 1,009 934 $233K
36455 671 636 $213K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,323 1,249 $208K
96375 Therapeutic injection; each additional sequential IV push 3,086 2,108 $156K
86780 8,218 7,785 $153K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 219 210 $147K
86703 8,516 8,086 $139K
95782 163 162 $138K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1,614 540 $137K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 3,014 2,917 $125K
84443 Thyroid stimulating hormone (TSH) 5,255 4,985 $115K
87088 10,112 9,634 $112K
82728 5,162 4,517 $96K
81001 25,083 23,933 $94K
A0425 Ground mileage, per statute mile 829 498 $94K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 2,547 2,474 $94K
A0427 Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 287 169 $92K
J3490 Unclassified drugs 5,538 3,741 $91K
80048 Basic metabolic panel (calcium, ionized) 11,967 10,903 $91K
81025 10,898 10,389 $91K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 76 76 $90K
86850 5,292 4,580 $83K
99157 195 191 $82K
J9271 Injection, pembrolizumab, 1 mg 65 50 $81K
36430 173 102 $63K
86922 427 397 $61K
85045 11,038 9,935 $61K
83020 3,176 3,014 $58K
86762 2,748 2,609 $55K
82570 6,778 6,293 $53K
76770 311 310 $50K
84439 3,956 3,845 $49K
87631 563 548 $48K
86787 2,613 2,484 $46K
62323 252 250 $46K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 517 161 $44K
87641 1,834 1,764 $44K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 630 590 $44K
A0426 Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) 362 218 $43K
36415 Collection of venous blood by venipuncture 18,237 15,392 $43K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 171 153 $43K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 612 445 $42K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 592 515 $39K
88142 1,373 1,291 $38K
80061 Lipid panel 2,201 2,078 $37K
86923 326 278 $37K
36591 2,290 1,363 $36K
74177 Computed tomography, abdomen and pelvis; with contrast material 41 38 $36K
86803 1,642 1,540 $35K
87340 2,805 2,667 $35K
80069 3,282 3,031 $35K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,171 1,035 $35K
81003 11,562 10,982 $33K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 707 579 $32K
84156 6,068 5,496 $30K
86902 986 918 $30K
83735 6,007 4,848 $30K
82962 7,901 7,397 $30K
J2469 Injection, palonosetron hcl, 25 mcg 114 75 $30K
87081 3,659 3,526 $27K
84484 2,277 1,931 $26K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit 84 76 $24K
86900 5,977 5,163 $24K
71250 134 128 $24K
86901 5,977 5,163 $24K
96361 Intravenous infusion, hydration; each additional hour 317 222 $24K
83021 979 924 $23K
82784 727 720 $23K
83615 2,836 2,600 $23K
70450 Computed tomography, head or brain; without contrast material 57 49 $22K
82951 1,118 1,014 $21K
83690 2,417 2,263 $21K
70551 Magnetic resonance imaging, brain; without contrast material 24 24 $20K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,473 1,443 $20K
96376 215 82 $18K
J0561 Injection, penicillin g benzathine, 100,000 units 80 60 $18K
85027 1,996 1,645 $18K
J7030 Infusion, normal saline solution , 1000 cc 2,762 1,304 $17K
87150 404 391 $17K
71260 Computed tomography, thorax, diagnostic; with contrast material 54 51 $17K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 147 108 $15K
83036 Hemoglobin; glycosylated (A1C) 1,084 1,006 $14K
J0475 Injection, baclofen, 10 mg 40 36 $14K
82610 558 544 $12K
84466 666 592 $12K
86160 429 423 $12K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,529 1,344 $11K
86141 651 636 $11K
83540 1,170 1,081 $11K
84100 4,099 3,216 $10K
78815 Positron emission tomography (PET) for limited area imaging 27 27 $10K
74240 25 25 $10K
82607 432 415 $10K
86162 411 405 $10K
85660 983 915 $9K
87430 642 635 $9K
82950 1,455 1,423 $9K
99155 59 55 $8K
92567 337 324 $8K
83970 242 229 $8K
92588 54 54 $8K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 27 26 $7K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 746 627 $7K
84300 1,120 1,107 $7K
74018 65 64 $7K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,191 1,107 $7K
93886 27 25 $6K
87077 571 543 $6K
84133 1,100 1,088 $6K
87070 532 523 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 87 83 $6K
83880 134 118 $6K
84702 476 427 $6K
80197 2,502 1,850 $6K
85007 1,244 938 $6K
84703 484 451 $5K
82550 725 718 $5K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 160 154 $5K
82565 767 738 $5K
86832 172 165 $4K
80051 587 570 $4K
83002 152 148 $4K
87799 1,096 954 $4K
86833 172 165 $4K
83001 139 135 $4K
76937 73 70 $3K
87497 758 678 $3K
92579 59 57 $3K
82657 71 68 $3K
J3535 Drug administered through a metered dose inhaler 67 66 $3K
84403 71 71 $3K
82043 378 372 $3K
84425 90 80 $3K
J1040 Injection, methylprednisolone acetate, 80 mg 205 201 $3K
85652 802 787 $3K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 39 38 $2K
86592 466 457 $2K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 12 12 $2K
0352U 81 78 $2K
84305 117 117 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 339 300 $2K
82670 53 50 $2K
82088 35 35 $2K
82746 84 74 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling 34 31 $2K
88342 13 13 $2K
J2704 Injection, propofol, 10 mg 181 165 $2K
87205 277 256 $2K
A9585 Injection, gadobutrol, 0.1 ml 56 52 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 54 52 $2K
J2405 Injection, ondansetron hydrochloride, per 1 mg 410 371 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor 26 26 $1K
84550 872 860 $1K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 42 42 $1K
82040 169 153 $1K
82157 26 26 $1K
82105 66 66 $1K
87210 233 214 $1K
96417 17 12 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 31 15 $1K
82677 42 42 $1K
A4217 Sterile water/saline, 500 ml 241 221 $1K
82627 28 28 $1K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 13 12 $1K
83655 68 65 $1K
84244 32 32 $876.80
97161 12 12 $876.03
J1170 Injection, hydromorphone, up to 4 mg 32 12 $872.23
64642 14 14 $858.70
64644 16 12 $850.80
86336 42 42 $838.00
A9575 Injection, gadoterate meglumine, 0.1 ml 15 12 $746.29
85018 260 245 $731.32
S0020 Injection, bupivicaine hydrochloride, 30 ml 202 182 $699.10
85014 261 241 $693.38
86769 42 41 $678.37
97530 Therapeutic activities, direct patient contact, each 15 minutes 16 12 $653.28
82340 84 82 $538.67
87496 174 136 $530.04
J0690 Injection, cefazolin sodium, 500 mg 116 97 $481.07
Q3014 Telehealth originating site facility fee 100 80 $468.80
80177 30 26 $457.38
83520 27 27 $446.85
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 12 12 $426.10
76377 64 64 $385.65
84153 26 24 $335.50
J7120 Ringers lactate infusion, up to 1000 cc 44 39 $308.56
G0239 Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) 73 13 $292.66
84075 196 173 $284.37
82310 158 142 $271.30
84481 12 12 $262.39
87040 13 13 $249.38
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 52 42 $236.28
J2250 Injection, midazolam hydrochloride, per 1 mg 75 74 $233.63
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 13 13 $191.52
80500 13 12 $178.80
83605 13 12 $178.24
87522 Neg quan hep c or qual rna 18 15 $170.44
82378 17 12 $165.48
84165 27 26 $163.00
85730 42 38 $142.12
84520 771 740 $126.90
82947 606 586 $115.38
84155 187 169 $108.07
J3010 Injection, fentanyl citrate, 0.1 mg 25 24 $100.96
87186 13 12 $97.57
82248 13 13 $96.73
85610 61 51 $94.46
83521 27 26 $82.82
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 766 588 $56.55
84436 41 39 $49.96
J0696 Injection, ceftriaxone sodium, per 250 mg 13 12 $43.42
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 15 14 $22.25
C1769 Guide wire 13 12 $15.77
84132 13 12 $5.72
0100U 49 45 $0.00